BIO101 stimulates myoblast differentiation and improves muscle function in adult and old mice
Abstract Background Muscle aging is associated with a consistent decrease in the ability of muscle tissue to regenerate following intrinsic muscle degradation, injury or overuse. Age‐related imbalance of protein synthesis and degradation, mainly regulated by AKT/mTOR pathway, leads to progressive lo...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-02-01
|
| Series: | Journal of Cachexia, Sarcopenia and Muscle |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/jcsm.13326 |
| _version_ | 1797335198844583936 |
|---|---|
| author | Maria Serova Blaise Didry‐Barca Robin Deloux Anne‐Sophie Foucault Stanislas Veillet René Lafont Pierre J. Dilda Mathilde Latil |
| author_facet | Maria Serova Blaise Didry‐Barca Robin Deloux Anne‐Sophie Foucault Stanislas Veillet René Lafont Pierre J. Dilda Mathilde Latil |
| author_sort | Maria Serova |
| collection | DOAJ |
| description | Abstract Background Muscle aging is associated with a consistent decrease in the ability of muscle tissue to regenerate following intrinsic muscle degradation, injury or overuse. Age‐related imbalance of protein synthesis and degradation, mainly regulated by AKT/mTOR pathway, leads to progressive loss of muscle mass. Maintenance of anabolic and regenerative capacities of skeletal muscles may be regarded as a therapeutic option for sarcopenia and other muscle wasting diseases. Our previous studies have demonstrated that BIO101, a pharmaceutical grade 20‐hydroxyecdysone, increases protein synthesis through the activation of MAS receptor involved in the protective arm of renin‐angiotensin‐aldosterone system. The purpose of the present study was to assess the anabolic and pro‐differentiating properties of BIO101 on C2C12 muscle cells in vitro and to investigate its effects on adult and old mice models in vivo. Methods The effects of BIO101 on C2C12 differentiation were assessed using myogenic transcription factors and protein expression of major kinases of AKT/mTOR pathway by Western blot. The in vivo effects of BIO101 have been investigated in BIO101 orally‐treated (50 mg/kg/day) adult mice (3 months) for 28 days. To demonstrate potential beneficial effect of BIO101 treatment in a sarcopenic mouse model, we use orally treated 22‐month‐old C57Bl6/J mice, for 14 weeks with vehicle or BIO101. Mice body and muscle weight were recorded. Physical performances were assessed using running capacity and muscle contractility tests. Results Anabolic properties of BIO101 were confirmed by the rapid activation of AKT/mTOR, leading to an increase of C2C12 myotubes diameters (+26%, P < 0.001). Pro‐differentiating effects of BIO101 on C2C12 myoblasts were revealed by increased expression of muscle‐specific differentiation transcription factors (MyoD, myogenin), resulting in increased fusion index and number of nuclei per myotube (+39% and +53%, respectively, at day 6). These effects of BIO101 were like those of angiotensin (1–7) and were abolished with the use of A779, a MAS receptor specific antagonist. Chronic BIO101 oral treatment induced AKT/mTOR activation and anabolic effects accompanied with improved physical performances in adult and old animals (maximal running distance and maximal running velocity). Conclusions Our data suggest beneficial anabolic and pro‐differentiating effects of BIO101 rendering BIO101 a potent drug candidate for treating sarcopenia and possibly other muscle wasting disorders. |
| first_indexed | 2024-03-08T08:33:27Z |
| format | Article |
| id | doaj.art-8728ef8a71da401fae8395131aae3c74 |
| institution | Directory Open Access Journal |
| issn | 2190-5991 2190-6009 |
| language | English |
| last_indexed | 2024-03-08T08:33:27Z |
| publishDate | 2024-02-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Cachexia, Sarcopenia and Muscle |
| spelling | doaj.art-8728ef8a71da401fae8395131aae3c742024-02-02T02:28:29ZengWileyJournal of Cachexia, Sarcopenia and Muscle2190-59912190-60092024-02-01151556610.1002/jcsm.13326BIO101 stimulates myoblast differentiation and improves muscle function in adult and old miceMaria Serova0Blaise Didry‐Barca1Robin Deloux2Anne‐Sophie Foucault3Stanislas Veillet4René Lafont5Pierre J. Dilda6Mathilde Latil7Biophytis Sorbonne Université Paris FranceBiophytis Sorbonne Université Paris FranceBiophytis Sorbonne Université Paris FranceBiophytis Sorbonne Université Paris FranceBiophytis Sorbonne Université Paris FranceBiophytis Sorbonne Université Paris FranceBiophytis Sorbonne Université Paris FranceBiophytis Sorbonne Université Paris FranceAbstract Background Muscle aging is associated with a consistent decrease in the ability of muscle tissue to regenerate following intrinsic muscle degradation, injury or overuse. Age‐related imbalance of protein synthesis and degradation, mainly regulated by AKT/mTOR pathway, leads to progressive loss of muscle mass. Maintenance of anabolic and regenerative capacities of skeletal muscles may be regarded as a therapeutic option for sarcopenia and other muscle wasting diseases. Our previous studies have demonstrated that BIO101, a pharmaceutical grade 20‐hydroxyecdysone, increases protein synthesis through the activation of MAS receptor involved in the protective arm of renin‐angiotensin‐aldosterone system. The purpose of the present study was to assess the anabolic and pro‐differentiating properties of BIO101 on C2C12 muscle cells in vitro and to investigate its effects on adult and old mice models in vivo. Methods The effects of BIO101 on C2C12 differentiation were assessed using myogenic transcription factors and protein expression of major kinases of AKT/mTOR pathway by Western blot. The in vivo effects of BIO101 have been investigated in BIO101 orally‐treated (50 mg/kg/day) adult mice (3 months) for 28 days. To demonstrate potential beneficial effect of BIO101 treatment in a sarcopenic mouse model, we use orally treated 22‐month‐old C57Bl6/J mice, for 14 weeks with vehicle or BIO101. Mice body and muscle weight were recorded. Physical performances were assessed using running capacity and muscle contractility tests. Results Anabolic properties of BIO101 were confirmed by the rapid activation of AKT/mTOR, leading to an increase of C2C12 myotubes diameters (+26%, P < 0.001). Pro‐differentiating effects of BIO101 on C2C12 myoblasts were revealed by increased expression of muscle‐specific differentiation transcription factors (MyoD, myogenin), resulting in increased fusion index and number of nuclei per myotube (+39% and +53%, respectively, at day 6). These effects of BIO101 were like those of angiotensin (1–7) and were abolished with the use of A779, a MAS receptor specific antagonist. Chronic BIO101 oral treatment induced AKT/mTOR activation and anabolic effects accompanied with improved physical performances in adult and old animals (maximal running distance and maximal running velocity). Conclusions Our data suggest beneficial anabolic and pro‐differentiating effects of BIO101 rendering BIO101 a potent drug candidate for treating sarcopenia and possibly other muscle wasting disorders.https://doi.org/10.1002/jcsm.1332620‐hydroxyecdysone (20E)EcdysteroidsMAS receptorMuscle cell differentiationRenin–angiotensin–aldosterone system (RAAS)Sarcopenia |
| spellingShingle | Maria Serova Blaise Didry‐Barca Robin Deloux Anne‐Sophie Foucault Stanislas Veillet René Lafont Pierre J. Dilda Mathilde Latil BIO101 stimulates myoblast differentiation and improves muscle function in adult and old mice Journal of Cachexia, Sarcopenia and Muscle 20‐hydroxyecdysone (20E) Ecdysteroids MAS receptor Muscle cell differentiation Renin–angiotensin–aldosterone system (RAAS) Sarcopenia |
| title | BIO101 stimulates myoblast differentiation and improves muscle function in adult and old mice |
| title_full | BIO101 stimulates myoblast differentiation and improves muscle function in adult and old mice |
| title_fullStr | BIO101 stimulates myoblast differentiation and improves muscle function in adult and old mice |
| title_full_unstemmed | BIO101 stimulates myoblast differentiation and improves muscle function in adult and old mice |
| title_short | BIO101 stimulates myoblast differentiation and improves muscle function in adult and old mice |
| title_sort | bio101 stimulates myoblast differentiation and improves muscle function in adult and old mice |
| topic | 20‐hydroxyecdysone (20E) Ecdysteroids MAS receptor Muscle cell differentiation Renin–angiotensin–aldosterone system (RAAS) Sarcopenia |
| url | https://doi.org/10.1002/jcsm.13326 |
| work_keys_str_mv | AT mariaserova bio101stimulatesmyoblastdifferentiationandimprovesmusclefunctioninadultandoldmice AT blaisedidrybarca bio101stimulatesmyoblastdifferentiationandimprovesmusclefunctioninadultandoldmice AT robindeloux bio101stimulatesmyoblastdifferentiationandimprovesmusclefunctioninadultandoldmice AT annesophiefoucault bio101stimulatesmyoblastdifferentiationandimprovesmusclefunctioninadultandoldmice AT stanislasveillet bio101stimulatesmyoblastdifferentiationandimprovesmusclefunctioninadultandoldmice AT renelafont bio101stimulatesmyoblastdifferentiationandimprovesmusclefunctioninadultandoldmice AT pierrejdilda bio101stimulatesmyoblastdifferentiationandimprovesmusclefunctioninadultandoldmice AT mathildelatil bio101stimulatesmyoblastdifferentiationandimprovesmusclefunctioninadultandoldmice |